Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer | MicrobiomeTrials← Back to trialsNCT00804154
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2009-08-14Est. Completion: 2027-02-07
Enrollment target: 45 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Rheumatoid Arthritis
In this 24-week, single center, randomized, double-blind, placebo-controlled study, the efficacy and safety of lyophilis…
Beijing, ChinaEst. completion Jun 1, 2028
Relapsed/Refractory Follicular LymphomaMarginal Zone Lymphoma
The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab…
Fresno, United StatesEst. completion Jul 2028
Relapsed or Refractory Multiple Myeloma
The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone …
Los Alamitos, United StatesEst. completion Jan 10, 2027